AC099850.3/NCAPG Axis Predicts Poor Prognosis and is Associated with Resistance to EGFR Tyrosine-Kinase Inhibitors in Lung Adenocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

AC099850.3/NCAPG Axis Predicts Poor Prognosis and is Associated with Resistance to EGFR Tyrosine-Kinase Inhibitors in Lung Adenocarcinoma

Published:2022-08 Issue: Volume:Volume 15 Page:6917-6930
ISSN:1178-7074
Container-title:International Journal of General Medicine
language:en
Short-container-title:IJGM

Author:

Bao Jiaqi,Wu Yanlong,Zhang Kun,Qi Huijuan^ORCID

Publisher

Informa UK Limited

Subject

General Medicine

Reference55 articles.

1. Cancer statistics, 2018

2. Lung Cancer: Understanding Its Molecular Pathology and the 2015 WHO Classification

3. Circ-AASDH functions as the progression of early stage lung adenocarcinoma by targeting miR-140-3p to activate E2F7 expression

4. Systemic Therapy for Locally Advanced and Metastatic Non–Small Cell Lung Cancer

5. Third-generation epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AC099850.3 promotes HBV-HCC cell proliferation and invasion through regulating CD276: a novel strategy for sorafenib and immune checkpoint combination therapy;Journal of Translational Medicine;2024-08-31

2. Important role and underlying mechanism of non‑SMC condensin I complex subunit G in tumours (Review);Oncology Reports;2024-04-15

3. The emerging role of noncoding RNAs in the EGFR signaling pathway in lung cancer;Pathology - Research and Practice;2024-01

4. Osimertinib resistance prognostic gene signature: STRIP2 is associated with immune infiltration and tumor progression in lung adenocarcinoma;Journal of Cancer Research and Clinical Oncology;2023-08-31

5. Identification and validation of a novel cuproptosis-related lncRNA signature for predicting colorectal cancer patients’ survival;Journal of Gastrointestinal Oncology;2023-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3